A Randomized Double Blind Phase II Trial of Restorative Microbiota Therapy (RMT) or Placebo in Combination with Durvalumab (MEDI4736) and Tremelimumab With Chemotherapy in Treatment Naïve Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer

Transitioning from individual clerkship, summative, graded evaluations to integrated, cross-clerkship, trajectory-driven assessments presents a challenge for clerkships and medical schools. We describe innovations and observations from a transition period during which the internal medicine clerkship integrated EPAs as a new, additional form of evaluation. We identify strategies that are effective in educating the hundreds of residents and evaluators utilizing these new evaluations, ranging from real-time faculty development tools to methods of student empowerment. We review which EPAs are most readily integrated into the workflow of the medicine clerkship and identify those that require a more intensive, targeted approach. We also reflect on the ongoing challenges to implementation, including specific faculty development needs and identifying threshold criteria across all courses that identify students ready for residency.